<DOC>
	<DOCNO>NCT01759706</DOCNO>
	<brief_summary>The purpose study assess adherence enhance recovery surgery ( ERAS ) pathway impact ERAS protocol postoperative short-term outcome patient undergo pancreaticoduodenectomy ( PD ) .</brief_summary>
	<brief_title>Safety Feasibility Study Enhanced Recovery Pancreaticoduodenectomy</brief_title>
	<detailed_description>A specific enhanced recovery surgery ( ERAS ) protocol apply since October 2010 consecutive patient undergo pancreaticoduodenectomy ( PD ) high volume Institution . Patient compliance item assess . Each ERAS patient match patient receive standard perioperative care . Match criterion age , gender , malignant / benign disease , PD prognostic score .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Diazepam</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>All patient undergo elective pancreaticoduodenectomy Intraoperative detection metastatic disease ( nonoperability )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>